Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | HDL Therapeutics, |
Description | Archives Menu Home About Team Pipeline News Contact HDL Therapeutics, Inc. Envisioning the future of atherosclerosis treatment HDL Therapeutics is revolutionizing |
Keywords | N/A |
WebSite | hdltherapeutics.com |
Host IP | 23.20.4.241 |
Location | United States |
Site | Rank |
US$2,965,821
Last updated: 2023-04-29 04:33:08
hdltherapeutics.com has Semrush global rank of 3,568,760. hdltherapeutics.com has an estimated worth of US$ 2,965,821, based on its estimated Ads revenue. hdltherapeutics.com receives approximately 342,211 unique visitors each day. Its web server is located in United States, with IP address 23.20.4.241. According to SiteAdvisor, hdltherapeutics.com is safe to visit. |
Purchase/Sale Value | US$2,965,821 |
Daily Ads Revenue | US$2,738 |
Monthly Ads Revenue | US$82,131 |
Yearly Ads Revenue | US$985,566 |
Daily Unique Visitors | 22,815 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
hdltherapeutics.com. | A | 599 | IP: 23.20.4.241 |
hdltherapeutics.com. | NS | 600 | NS Record: ns2.datahal.com. |
hdltherapeutics.com. | NS | 600 | NS Record: ns3.datahal.com. |
hdltherapeutics.com. | NS | 600 | NS Record: ns.datahal.com. |
hdltherapeutics.com. | MX | 600 | MX Record: 10 hdltherapeutics-com.mail.protection.outlook.com. |
hdltherapeutics.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
hdltherapeutics.com. | TXT | 600 | TXT Record: MS=ms85865096 |
Menu Home About Team Pipeline News Contact HDL Therapeutics, Inc. Envisioning the future of atherosclerosis treatment HDL Therapeutics is revolutionizing the way that patients with atherosclerosis not only manage their disease, but treat it. Learn About Us Novel Approach We are going where no one has gone before. Our PDS-2™ System is the only FDA-approved therapy designed to harness the power of HDL (“good cholesterol”) levels to regress plaques in the coronary arteries of patients with HoFH. Learn About Our Pipeline Expert Leadership HDL Therapeutics brings together expert talent with decades of experience in the pharmaceutical, biotechnology, and medical device industries. Meet Our Team Archives Categories No categories Meta Log in Entries feed Comments feed WordPress.org Proudly powered by WordPress | Theme: Lodestar by Automattic |
HTTP/1.1 301 Moved Permanently Date: Fri, 22 Oct 2021 03:22:07 GMT Server: Apache X-Powered-By: PHP/7.4.15 Expires: Fri, 22 Oct 2021 04:22:07 GMT Cache-Control: max-age=3600 X-Redirect-By: redirection X-Frame-Options: SAMEORIGIN Location: https://www.hdltherapeutics.com/ Content-Type: text/html; charset=UTF-8 HTTP/2 200 content-type: text/html; charset=UTF-8 date: Fri, 22 Oct 2021 03:22:07 GMT server: Apache x-powered-by: PHP/7.4.15 x-frame-options: SAMEORIGIN vary: Accept-Encoding cache-control: max-age=0, no-cache x-cache: Miss from cloudfront via: 1.1 e3bd3151a67fbf39759e8f681890f01e.cloudfront.net (CloudFront) x-amz-cf-pop: ORD52-C1 x-amz-cf-id: 9XvMJRafxICgZMKNCt5s2XC32Ev3Iy49WNpYDXT1AR6FLRdaUcUHxg== |
Domain Name: HDLTHERAPEUTICS.COM Registry Domain ID: 1589028284_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.advancedregistrar.com Registrar URL: http://www.netearthone.com Updated Date: 2021-03-08T16:40:33Z Creation Date: 2010-03-16T18:53:05Z Registry Expiry Date: 2022-03-16T18:53:05Z Registrar: NetEarth One Inc. d/b/a NetEarth Registrar IANA ID: 1005 Registrar Abuse Contact Email: a-b-u-s-e.whois.field@netearthone.com Registrar Abuse Contact Phone: +44 02030 26 99 87 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS.DATAHAL.COM Name Server: NS2.DATAHAL.COM Name Server: NS3.DATAHAL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T20:43:47Z <<< |